Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A cross-sectional study to compare care needs of individuals with and without dementia in residential homes in the Netherlands.

van der Ploeg ES, Bax D, Boorsma M, Nijpels G, van Hout HP.

BMC Geriatr. 2013 May 24;13:51. doi: 10.1186/1471-2318-13-51.

2.

Building for big pharma.

Giniatullina A, Boorsma M, Mulder GJ, van Deventer S.

Nat Biotechnol. 2013 Apr;31(4):284-7. No abstract available.

PMID:
23563416
3.

Implementation of geriatric assessment and decision support in residential care homes: facilitating and impeding factors during initial and maintenance phase.

Boorsma M, Langedijk E, Frijters DH, Nijpels G, Elfring T, van Hout HP.

BMC Health Serv Res. 2013 Jan 5;13:8. doi: 10.1186/1472-6963-13-8.

4.

The incidence of depression and its risk factors in Dutch nursing homes and residential care homes.

Boorsma M, Joling K, Dussel M, Ribbe M, Frijters D, van Marwijk HW, Nijpels G, van Hout H.

Am J Geriatr Psychiatry. 2012 Nov;20(11):932-42. doi: 10.1097/JGP.0b013e31825d08ac.

PMID:
22828203
5.

Is it time for a change? A cost-effectiveness analysis comparing a multidisciplinary integrated care model for residential homes to usual care.

MacNeil Vroomen JL, Boorsma M, Bosmans JE, Frijters DH, Nijpels G, van Hout HP.

PLoS One. 2012;7(5):e37444. doi: 10.1371/journal.pone.0037444. Epub 2012 May 24.

6.

The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes.

Boorsma M, Joling KJ, Frijters DH, Ribbe ME, Nijpels G, van Hout HP.

Int J Geriatr Psychiatry. 2012 Jul;27(7):709-15. doi: 10.1002/gps.2770. Epub 2011 Aug 27.

PMID:
21919058
7.

Effects of multidisciplinary integrated care on quality of care in residential care facilities for elderly people: a cluster randomized trial.

Boorsma M, Frijters DH, Knol DL, Ribbe ME, Nijpels G, van Hout HP.

CMAJ. 2011 Aug 9;183(11):E724-32. doi: 10.1503/cmaj.101498. Epub 2011 Jun 27.

9.

Depression in Dutch homes for the elderly: under-diagnosis in demented residents?

Baller M, Boorsma M, Frijters DH, van Marwijk HW, Nijpels G, van Hout HP.

Int J Geriatr Psychiatry. 2010 Jul;25(7):712-8. doi: 10.1002/gps.2412.

PMID:
19806603
10.

Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.

Bathoorn E, Liesker JJ, Postma DS, Boorsma M, Bondesson E, Koëter GH, Kauffman HF, van Oosterhout AJ, Kerstjens HA.

COPD. 2008 Oct;5(5):282-90. doi: 10.1080/15412550802363360.

PMID:
18972276
11.

The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial.

Boorsma M, van Hout HP, Frijters DH, Ribbe MW, Nijpels G.

BMC Health Serv Res. 2008 Jul 7;8:143. doi: 10.1186/1472-6963-8-143.

12.

Long-term effects of budesonide on inflammatory status in COPD.

Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.

COPD. 2008 Apr;5(2):97-104. doi: 10.1080/15412550801941000.

PMID:
18415808
13.

Evidence of the in vivo esterification of budesonide in human airways.

van den Brink KI, Boorsma M, Staal-van den Brekel AJ, Edsbäcker S, Wouters EF, Thorsson L.

Br J Clin Pharmacol. 2008 Jul;66(1):27-35. doi: 10.1111/j.1365-2125.2008.03164.x. Epub 2008 Apr 1.

14.

Repeatability of inflammatory parameters in induced sputum of COPD patients.

Boorsma M, Lutter R, van de Pol MA, Out TA, Jansen HM, Jonkers RE.

COPD. 2007 Dec;4(4):321-9.

PMID:
18027159
15.

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.

van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.

Pulm Pharmacol Ther. 2004;17(2):89-95.

PMID:
15123230
16.

Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter.

Tate CG, Haase J, Baker C, Boorsma M, Magnani F, Vallis Y, Williams DC.

Biochim Biophys Acta. 2003 Feb 17;1610(1):141-53.

17.

Alphavirus cDNA-based expression vectors: effects of RNA transcription and nuclear export.

Boorsma M, Saudan P, Pfruender H, Bailey JE, Schlesinger S, Renner WA, Bachmann MF.

Biotechnol Bioeng. 2003 Mar 5;81(5):553-62.

PMID:
12514804
18.

Bioprocess applications of a Sindbis virus-based temperature-inducible expression system.

Boorsma M, Hoenke S, Marrero A, Fischer R, Bailey JE, Renner WA, Bachmann MF.

Biotechnol Bioeng. 2002 Sep 20;79(6):602-9.

PMID:
12209807
19.

New applications of alphavirus-based expression vectors.

Boorsma M, Koller D, Renner WA, Bachmann MF.

Cytotechnology. 2001 May;35(3):203-12. doi: 10.1023/A:1013192017048.

20.

A temperature-regulated replicon-based DNA expression system.

Boorsma M, Nieba L, Koller D, Bachmann MF, Bailey JE, Renner WA.

Nat Biotechnol. 2000 Apr;18(4):429-32.

PMID:
10748525
21.
22.

Assessment of the relative systemic potency of inhaled fluticasone and budesonide.

Boorsma M, Andersson N, Larsson P, Ullman A.

Eur Respir J. 1996 Jul;9(7):1427-32.

23.
24.

Effect of theophylline and enprofylline on bronchial hyperresponsiveness.

Koëter GH, Kraan J, Boorsma M, Jonkman JH, van der Mark TW.

Thorax. 1989 Dec;44(12):1022-6.

25.

Dosage and time effects of inhaled budesonide on bronchial hyperreactivity.

Kraan J, Koëter GH, van der Mark TW, Boorsma M, Kukler J, Sluiter HJ, De Vries K.

Am Rev Respir Dis. 1988 Jan;137(1):44-8.

PMID:
3276257
26.

Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

Zaagsma J, Meems L, Boorsma M.

Naunyn Schmiedebergs Arch Pharmacol. 1977 May;298(1):29-36. No abstract available.

PMID:
18685
27.

[Instructional goals in nursing education].

Boorsma M.

Tijdschr Ziekenverpl. 1975 Aug 26;28(17):785-7. Dutch. No abstract available.

PMID:
1043474

Supplemental Content

Loading ...
Support Center